Does the Gut Microbiota Have a Role in Type 1 Diabetes? Early Evidence from Humans and Animal Models of the Disease

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2012 Aug 10

PMID 22875196

Citations 42

Authors

M A Atkinson

A Chervonsky

Affiliations

Soon will be listed here.

Abstract

Despite years of appreciating the potential role of environment to influence the pathogenesis of type 1 diabetes, specific agents or mechanisms serving in such a capacity remain ill defined. This is exceedingly disappointing as the identification of factors capable of modulating the disease, either as triggers or regulators of the autoimmune response underlying type 1 diabetes, would not only provide clues as to why the disorder develops but, in addition, afford opportunities for improved biomarkers of disease activity and the potential to design novel therapeutics capable of disease abatement. Recent improvements in sequencing technologies, combined with increasing appreciation of the role of innate and mucosal immunity in human disease, have stirred strong interest in what is commonly referred to as the 'gut microbiota'. The gut (or intestinal) microbiota is an exceedingly complex microenvironment that is intimately linked with the immune system, including the regulation of immune responses. After evaluating evidence supporting a role for environment in type 1 diabetes, this review will convey current notions for contributions of the gut microbiota to human health and disease, including information gleaned from studies of humans and animal models for this autoimmune disorder.

Citing Articles

Accelerated onset of diabetes in non-obese diabetic mice fed a refined high-fat diet.

Batdorf H, Lawes L, Cassagne G, Fontenot M, Harvey I, Richardson J Diabetes Obes Metab. 2024; 26(6):2158-2166.

PMID: 38433703 PMC: 11078605. DOI: 10.1111/dom.15522.

Current progress and critical challenges to overcome in the bioinformatics of mass spectrometry-based metaproteomics.

Miura N, Okuda S Comput Struct Biotechnol J. 2023; 21:1140-1150.

PMID: 36817962 PMC: 9925844. DOI: 10.1016/j.csbj.2023.01.015.

Probiotic normalization of systemic inflammation in siblings of type 1 diabetes patients: an open-label pilot study.

Cabrera S, Coren A, Pant T, Ciecko A, Jia S, Roethle M Sci Rep. 2022; 12(1):3306.

PMID: 35228584 PMC: 8885673. DOI: 10.1038/s41598-022-07203-6.

Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice.

Zhang X, Yin Y, Wang J, Battaglia T, Krautkramer K, Li W Cell Host Microbe. 2021; 29(8):1249-1265.e9.

PMID: 34289377 PMC: 8370265. DOI: 10.1016/j.chom.2021.06.014.

Programming gene expression in multicellular organisms for physiology modulation through engineered bacteria.

Gao B, Sun Q Nat Commun. 2021; 12(1):2689.

PMID: 33976154 PMC: 8113242. DOI: 10.1038/s41467-021-22894-7.

References

Brugman S, Klatter F, Visser J, Wildeboer-Veloo A, Harmsen H, Rozing J . Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia. 2006; 49(9):2105-8. DOI: 10.1007/s00125-006-0334-0. View

Geuking M, Cahenzli J, Lawson M, Ng D, Slack E, Hapfelmeier S . Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity. 2011; 34(5):794-806. DOI: 10.1016/j.immuni.2011.03.021. View

Lee A, Gibson D, Zhang Y, Sham H, Vallance B, Dutz J . Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia. 2009; 53(4):741-8. DOI: 10.1007/s00125-009-1626-y. View

Brown C, Davis-Richardson A, Giongo A, Gano K, Crabb D, Mukherjee N . Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One. 2011; 6(10):e25792. PMC: 3197175. DOI: 10.1371/journal.pone.0025792. View

Satoh J, Shintani S, Oya K, Tanaka S, Nobunaga T, Toyota T . Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes. 1988; 37(9):1188-94. DOI: 10.2337/diab.37.9.1188. View

Sapone A, de Magistris L, Pietzak M, Clemente M, Tripathi A, Cucca F . Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006; 55(5):1443-9. DOI: 10.2337/db05-1593. View

Vaarala O, Atkinson M, Neu J . The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008; 57(10):2555-62. PMC: 2551660. DOI: 10.2337/db08-0331. View

Bach J . Six questions about the hygiene hypothesis. Cell Immunol. 2005; 233(2):158-61. DOI: 10.1016/j.cellimm.2005.04.006. View

Cerf-Bensussan N, Gaboriau-Routhiau V . The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol. 2010; 10(10):735-44. DOI: 10.1038/nri2850. View

10.

Coppieters K, Boettler T, von Herrath M . Virus infections in type 1 diabetes. Cold Spring Harb Perspect Med. 2012; 2(1):a007682. PMC: 3253029. DOI: 10.1101/cshperspect.a007682. View

11.

Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C . The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009; 31(4):677-89. DOI: 10.1016/j.immuni.2009.08.020. View

12.

Macpherson A, Harris N . Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004; 4(6):478-85. DOI: 10.1038/nri1373. View

13.

Ley R, Lozupone C, Hamady M, Knight R, Gordon J . Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol. 2008; 6(10):776-88. PMC: 2664199. DOI: 10.1038/nrmicro1978. View

14.

Gale E . Type 1 diabetes in the young: the harvest of sorrow goes on. Diabetologia. 2005; 48(8):1435-8. DOI: 10.1007/s00125-005-1833-0. View

15.

Scher J, Abramson S . The microbiome and rheumatoid arthritis. Nat Rev Rheumatol. 2011; 7(10):569-78. PMC: 3275101. DOI: 10.1038/nrrheum.2011.121. View

16.

Hamady M, Knight R . Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res. 2009; 19(7):1141-52. PMC: 3776646. DOI: 10.1101/gr.085464.108. View

17.

Wasserfall C, Nead K, Mathews C, Atkinson M . The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes. Diabetologia. 2011; 54(9):2232-6. PMC: 7296551. DOI: 10.1007/s00125-011-2244-z. View

18.

Martin R, Nauta A, Ben Amor K, Knippels L, Knol J, Garssen J . Early life: gut microbiota and immune development in infancy. Benef Microbes. 2011; 1(4):367-82. DOI: 10.3920/BM2010.0027. View

19.

Qin H, Singh B . BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J Autoimmun. 1997; 10(3):271-8. DOI: 10.1006/jaut.1997.0136. View

20.

Roesch L, Lorca G, Casella G, Giongo A, Naranjo A, Pionzio A . Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J. 2009; 3(5):536-48. PMC: 2972309. DOI: 10.1038/ismej.2009.5. View